| Name | BI-2081 |
|---|
| Description | BI-2081 is a GPR40 (FFAR1) partial agonist (EC50: 4 nM). BI-2081 induces glucose depending insulin secretion and reduces the plasma glucose concentration. BI-2081 can be used in the research of metabolic diseases, in particular diabetes type 2[1]. |
|---|---|
| Related Catalog | |
| Target |
GPR40 (FFAR1)[1] |
| References |
| Molecular Formula | C32H35FO6 |
|---|---|
| Molecular Weight | 534.62 |